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Transforming
trauma care
Artificial blood, other innovations
could save lives
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Rupa Patel, MD, MPH, speaks with
Keith Cotton, owner of Boardwalk
Waffles & Ice Cream in St. Louis, about
PrEP, a single daily pill that helps prevent
HIV. As part of her community outreach
efforts, Patel distributes informational
posters on PrEP to local businesses.
See page 10.
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Infectious disease doctor Rupa Patel is raising worldwide aware-

COVER ErythroMer, a red blood cell

substitute formulated from freeze-dried
hemoglobin (shown above), which has
shown success in small animal trials, may
become available for human use within 10
years. On the battlefield and in desolate
locations, such a preparation could be
mixed with water at the point of care to
treat traumatic bleeding. See page 16.
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Jennifer Duong, left, and
Rosie Tang show off their
Match Day letters. Duong is
headed to Seattle Children’s
Hospital for pediatrics; Tang is
going to Duke University for
anesthesiology. See page 24.
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As her premature baby struggled for survival in
the neonatal intensive care unit, Robin TorrenceWebber, right, became anxious and depressed.
She credits therapist Anna Constantino-Pettit,
MSW ’14, left, with lifting her spirits and teaching
her to cope. See page 26.
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Study findings suggest that
current allowable limits for
manganese exposure are not
adequately protecting welders.

Danger in the workplace

Manganese-containing welding fumes linked to neurological problems

W

elders exposed to airborne
manganese at estimated
levels below federal
occupational safety standards exhibit
neurological problems similar to
Parkinson’s disease, according to
new research.
The findings, published Dec. 28
in Neurology, suggest that current
safety standards may not adequately
protect welders.
“We found that chronic exposure to
manganese-containing welding fumes is
associated with progressive neurological
symptoms,” said Brad A. Racette, MD, a
professor of neurology and the study’s
senior author. “The more exposure you
have to welding fumes, the more quickly
those symptoms progress over time.”

2 Washington University School of Medicine

At high levels, manganese — a key
component of important industrial
processes such as welding and steelmaking
— can cause manganism, a severe
neurologic disorder with symptoms similar
to Parkinson’s disease, including slowness,
clumsiness, tremors, mood changes and
difficulty walking and speaking.
Decades ago, this risk drove the
Occupational Safety and Health
Administration (OSHA) to set standards
limiting the amount of manganese in the
air at workplaces. These safety standards
are widely believed to have eliminated
manganism as an occupational hazard.
Researchers, however, have long
suspected that there may still be some
health effects at levels much lower than
what is allowable per OSHA standards.

This is the first study showing clinically
relevant health effects occurring at estimated
exposures lower than the OSHA limit.
Racette and colleagues studied 886
welders at three worksites in the Midwest
— two shipyards and one heavymachinery fabrication shop. Each welder
filled out a detailed job history
questionnaire and underwent at least two
standardized clinical evaluations of motor
function spaced a year or more apart.
The most worrisome aspect of the
study, Racette said, is that the
neurological signs showed up in people
with an estimated exposure of only 0.14
milligrams of manganese per cubic meter
of air, far below the safety standard set by
OSHA at 5 milligrams per cubic meter.
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U.S. hospitals can improve patient care and reduce costs if
cardiologists perform more coronary angioplasties through
wrist arteries, and if they take steps to discharge patients on
the same day, according to a new study.
Coronary angioplasty, also called percutaneous coronary
intervention (PCI), is performed to alleviate chest pain or
shortness of breath. Interventional cardiologists increase
blood flow to the heart by inserting a small tube via an artery
in the groin or wrist, opening up the narrowed section with
an inflatable balloon, and possibly placing a stent.
Shifting standard practice by 30 percent — from the groin
to the wrist approach — along with same-day discharge,
could save the U.S.
$300 million per year,
researchers estimate.
“The traditional way
has been to go through
the bigger femoral
artery that is a straight
pathway to the heart,”
said first author Amit P.
Amin, MD, an assistant
professor of medicine.
“Unfortunately, that
artery is also deep. It’s
associated with more bleeding complications. When we go
in through a vessel in the wrist, we see less bleeding, fewer
complications, less pain and discomfort, higher patient
satisfaction, shorter hospital stays and lower costs.”
Improved technology has allowed wrist access to
become a viable route, even for complex cases, Amin said.
The researchers analyzed data from almost 280,000
Medicare patients who underwent PCI and were eligible for
same-day discharge. Only about 5 percent of these patients
actually were discharged prior to staying overnight.
“We have seen that it is very safe to send these patients
home the same day,” Amin said. “We use risk-prediction
models to predict their risks ahead of time, and we plan
ahead to mitigate any issues so we can facilitate a same-day
discharge. We want to outline health-care pathways that
provide the best care for patients.”
For the groin approach with at least one night of
hospitalization, the average cost is $17,076. The average cost
for the wrist approach with same-day discharge is $13,389.
Independent of the length of stay, the wrist approach costs
about $900 less than the groin approach.
Health-care costs for the 600,000 patients who receive
PCI annually in the U.S. are estimated at $10 billion.
outlook.wustl.edu

MUCHLOVED EDUCATORS Glenn C. Conroy,
PhD, and Jane Phillips-Conroy, PhD, celebrated retirement
this April. The Conroys have taught anatomy to every single
medical student for the past 32 years, since joining the faculty
in 1983. They are revered by medical students not only as
accomplished anthropologists, but for their skill and dedication in teaching the Human Anatomy and Development
course, a cornerstone of the medical school experience.

Brain hardwired to respond to itching
Yawning and scratching are socially contagious behaviors; if
one person does it, others are likely to follow suit. School of
Medicine researchers now have found that socially contagious
itching is hardwired in the brain. The discovery, published
in Science, may help scientists understand the neural circuits
that control socially contagious behaviors.
Researchers put a mouse in
an enclosure with a computer
screen, and then played a
video showing another mouse
scratching. Within seconds, the
mouse in the enclosure started
scratching, too.
Next, the researchers zeroed
in on a brain region called the
suprachiasmatic nucleus, which
regulates sleep/wake cycles.
When the mouse saw other mice
scratching, this nucleus released a chemical substance
called GRP (gastrin-releasing peptide).
“The mouse doesn’t see another mouse scratching and
then think it might need to scratch, too,” said principal
investigator Zhou-Feng Chen, PhD, director of the Center
for the Study of Itch. “Instead, its brain begins sending out
itch signals using GRP as a messenger.”
When Chen’s team used various methods to block the
chemical or receptors, the mice did not scratch when they
saw others scratch.
“Many people thought it was all in the mind, but our
experiments show it is a hardwired behavior and is not a
form of empathy,” Chen said.
MIKE WORFUL

THINKSTOCK

Heart procedure changes
could improve outcomes
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DISTINGUISHED CONTRIBUTIONS Three
professors have been selected as fellows of the American
Association for the Advancement of Science, the world’s
largest general scientific society. From left, the fellows are:
Azad Bonni, MD, PhD, the Edison Professor of Neurobiology
and head of the Department of Neuroscience; Phyllis I.
Hanson, MD, PhD, the Gerty T. Cori Professor at the School
of Medicine; and Gary D. Stormo, PhD, the Joseph Erlanger
Professor in the Department of Genetics.

Scheel to head faculty practice plan
Paul J. Scheel Jr., MD, a physicianleader at Johns Hopkins University
School of Medicine, has been
named associate vice chancellor
for clinical affairs at Washington
University School of Medicine and
chief executive officer of Washington
University Physicians, the school’s
faculty practice group. His appointPaul J. Scheel Jr., MD
ment begins July 1.
Washington University Physicians ranks among the
largest academic group practices in the U.S.
Scheel serves as vice president of the Office of Johns
Hopkins Physicians in the Johns Hopkins Health System
and medical director of Integrated Renal Solutions of
Johns Hopkins Healthcare in Baltimore. He also is the
Ronald Peterson Professor of Medicine and director of
the Division of Nephrology at Johns Hopkins University
School of Medicine.
Scheel succeeds James P. Crane, MD, associate vice
chancellor for clinical affairs, who led Washington
University Physicians for 25 years. In that time, the
clinical practice has grown substantially and draws
patients from across the country.
Paul Scheel’s wife, Janet Scheel, MD, will join the
Department of Pediatrics as associate medical director
of the heart failure and transplant program in the
Division of Cardiology.
The Scheels have two children: Paul recently graduated
from Washington University School of Medicine and is an
intern at Johns Hopkins; Amy works in public health and
conducts research in Uganda.
4 Washington University School of Medicine

Women who pursue in vitro fertilization (IVF) are more
likely to give birth if they have health insurance that covers
the procedure, according to new research.
The key reason is financial: The high cost prohibits most
women from seeking a second treatment if the first attempt fails.
The study is published in The Journal of the American
Medical Association.
“It’s a simple and
possibly obvious
finding, but it highlights the importance
of health insurance
in the outcome of
fertility treatments,”
said lead author
Emily S. Jungheim,
MD, an associate
professor of obstetrics Emily S. Jungheim, MD, examines oocytes retrieved
during an in vitro fertilization procedure.
and gynecology.
“The biggest hurdle
may not be the fertility treatment but the cost.”
The American Pregnancy Association estimates the cost
of a single IVF treatment at $12,000 to $17,000. The success
of one IVF procedure ranges from more than 40 percent for
women under age 35 to about 15 percent for women over age
40. Other factors influencing success include lifestyle, cause
of infertility and reproductive history.
The study examined data from 1,572 women seeking
IVF treatment from 2001 to 2010 at Washington University’s
Fertility and Reproductive Medicine Center. The clinic
serves women in Missouri and Illinois. The location is
significant to study findings as Illinois mandates IVF
coverage, while Missouri does not.
Seventy percent of women with insurance returned for a
second IVF treatment if the first treatment was unsuccessful.
For women with coverage, the average likelihood of
giving birth after up to four attempts was 59 percent, or
515 births. This compared with 51 percent, or 350 births,
for women without such coverage — a difference that is
statistically significant.
Fifteen states have infertility insurance laws; however, only
five have comprehensive mandates that include IVF: Illinois,
Massachusetts, Rhode Island, Connecticut and New Jersey.
Researchers from Washington University’s Olin Business
School and the Brown School contributed to the study.
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Insurance influences
pregnancy success

#ILookLikeASurgeon

GREG BARNETT

A magazine cover from The New Yorker
inspired women surgeons worldwide
to post pictures of themselves on social
media and, of course, Washington
University had to take part. Left,
female surgeons from the School of
Medicine re-create the cover pose.
French artist Malika Favre created
the April 3 cover illustration for The
New Yorker from the perspective of a
patient, with four female surgeons peering down. The illustration soon
went viral, as women surgeons took work selfies and posted them on
Twitter, Facebook and Instagram. In covering the trend, CBS News highlighted the Washington University photo.

A

combination of two topical
drugs that have been in use for
years triggers a robust immune
response against precancerous skin lesions,
according to researchers from Washington
University and Harvard medical schools.
The study, involving 132 patients with
actinic keratosis, a precursor to squamous
cell carcinoma, is published in The Journal
of Clinical Investigation.
“We looked at precancerous lesions
on patients with sun-damaged skin,” said
study co-author Lynn A. Cornelius, MD, the
Winfred A. and Emma R. Showman Professor
of Dermatology and director of the Division
of Dermatology. “Most commonly found on
the face, scalp and arms, these lesions appear
abnormal by visual examination and under the
microscope but are not full-blown skin cancers.”
These lesions have the potential to
develop into a true skin cancer and are
commonly treated.
On average, the investigational therapy
reduced the number of precancerous skin
lesions on the face by almost 88 percent
compared with a 26 percent reduction using
the standard chemotherapy.
While side effects such as skin scaling and
itching were similar with both treatments,

outlook.wustl.edu

patients receiving the
investigational therapy
reported more redness
and increased burning
sensations, which
are consistent with
the immune response
it triggers.
Interestingly, although
not specifically measured,
patients who had been
treated previously with
conventional therapies
reported decreased pain
and discomfort with the
combination treatment, Cornelius said.
The investigational treatment combines
5-fluorouracil, a cream formulation of a
chemotherapy drug prescribed to treat actinic
keratosis, with a synthetic form of vitamin
D called calcipotriol. The FDA has approved
calcipotriol for treatment of psoriasis, an
autoimmune disorder characterized by red,
scaly patches of skin.
Prior studies in mice prone to allergic
inflammation, especially eczema on the skin,
suggest that overreactive immunity triggered
by damaged skin may have a significant
benefit — a hyper-vigilant system that
attacks cancerous cells.

ROBERT BOSTON

Topical drugs effective against early skin cancer

Dermatologist Lynn A. Cornelius, MD, left, conducts
a skin exam with patient Robert Manchester.

Earlier work at Washington University by
senior author Shadmehr Demehri, MD, PhD,
now at Harvard, showed that a protein in
the skin called TSLP activates the immune
system’s T cells. Calcipotriol also is known to
cause the skin to produce TSLP.
The therapy induces a heightened
immune response in the skin, and the
chemotherapy drug works to destroy the
cancerous cells.

Outlook 5

Weight-loss therapy rids body of food
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Aspiration therapy offers significantly overweight people a
means to rid their bodies of excess calories before digestion.
The FDA-approved, nonsurgical therapy was developed
by School of Medicine researchers, who have been following
study patients for three years. “It’s been very successful,
with study patients losing an average of 14 percent of their
total body weight, almost double the amount seen with
other nonsurgical
procedures and similar
to weight loss seen
with some surgical
procedures,” said
Vladimir Kushnir, MD,
an assistant professor
of medicine and
director of the Bariatric
Endoscopy Program.
Kushnir uses an
endscope
to place a
Vladimir Kushnir, MD, and research
small,
discreet
device
coordinator and dietitian Abigail Lowe.
into the stomach, a tube
that is undetectable beneath a shirt or a one-piece bathing
suit. That tube, similar to a port used to get drugs into the
body, protrudes slightly from the skin.
For the device to work, a patient goes to a restroom
30 to 60 minutes after eating, connects the tube to an
Enjoy interactive elements and added content
external apparatus and removes about one-third of the
food eaten. Most patients perform aspiration therapy once
or twice each day, after the largest meals they consume.
6 Washington University School of Medicine

Brain networks may underlie social behavior
School of Medicine researchers are key collaborators in
a multicenter study that has found associations between
brain connectivity and a social behavior that is a key
feature of autism.
Conducted through the Infant Brain Imaging Study
network, the collaboration also included scientists from the
University of North Carolina, The Children’s Hospital of
Philadelphia and the University of Washington.
Using functional MRI, researchers sought to identify
brain networks involved in “initiation of joint attention.”
This is what it’s called when a baby sees an object, such as
a dog or a ball, focuses
on that object and —
by pointing and/or
shifting gaze — gets
someone else to focus
on that object, too.
It’s a behavior that is
impaired in children
with autism spectrum
disorder.
“By the time most
children are diagnosed Brain networks may play a role when a child sees
with autism, they are
an object and gets someone else to focus on the
4 ½, but in studying
object, too.
the brains of younger
children, we have found neural activity that may allow for
earlier diagnosis, and that, in turn, may allow us to begin
treatment sooner,” said John R. Pruett Jr., MD, PhD, cosenior author and an associate professor of child psychiatry.
The researchers scanned the brains of more than
200 sleeping toddlers. The next day, researchers watched
to see how often the children initiated joint attention.
Those less likely to initiate joint attention had strong
connections between their brains’ visual and dorsal
attention networks. The dorsal attention network keeps
focused attention on something while still allowing the
brain to respond to other sensory information.
Those more likely to initiate joint attention had stronger
functional connectivity between the visual and the default
mode networks. The default mode network is most active
during quiet rest or daydreaming but generally shuts down
while one is focused on a challenging task.
First author Adam T. Eggebrecht, PhD, an instructor in
radiology, said the visual and default mode regions tend to
work together, while the visual and attention regions tend
to decouple: “In these scans we’re seeing something like a
fingerprint of how brain networks coordinate activity.”
Spring 2017
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COURTESY OF THE SENATE APPROPRIATIONS COMMITTEE

NATIONAL LEADERSHIP Timothy J. Eberlein, MD,
head of the Department of Surgery, testifies before a U.S.
Senate subcommittee March 8 regarding federal funding
for medical research. Such funding is critical in developing
innovative therapies and vital to the careers of young scientists
whose ideas and work help improve patient outcomes, he
said. The subcommittee makes recommendations on National
Institutes of Health (NIH) funding. Sen. Roy Blunt, R-Mo., the
subcommittee chairman, invited Eberlein to testify.

Insights into autism

Building connections
A new campus plan brings communities together and improves
the experience for employees, patients, students and visitors.
BY GAIA REMEROWSKI

outlook.wustl.edu
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Serendipity
as strategy
ver the past few years,
Washington University
Medical Center has been abuzz with
construction, renovation and relocation
of many departments. Behind this
seemingly chaotic scene is a highly
structured physical campus plan
aimed at better integrating education
and work spaces, student housing,
pedestrian paths, and retail and social
offerings. The hope behind such efforts
is to forge new connections and improve
the overall experience for those who
frequent this bustling urban campus.
“Our goal is to bring people together
in ways they haven’t connected before
and to make our campus more inviting
for visitors, patients, students and
employees,” said Melissa Hopkins,
the school’s assistant vice chancellor
and assistant dean of operations and
facilities management.
Working with hospital partners and
the neighboring Cortex Innovation
Community, planners have undertaken
a comprehensive review — looking
at everything from changing healthcare needs and daily traffic patterns to
operational efficiency and sustainability.
The key objectives: enhance
education, drive talent, improve access
and safety, expand clinical care and
achieve better health outcomes.
CO L L A B O R AT I O N
AMENITIES
STUDENT LIFE
PAT H WAYS
CLINICAL CARE
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CO L L A B O R AT I O N
Many operational and administrative
services of the medical school and BJC
HealthCare now are housed together in
the new Mid Campus Center, located
in the heart of campus. The 12-story
building includes a joint emergency
command center and enhanced
meeting rooms and consolidates
the school’s administrative offices,
including the Dean’s office, Human
Resources, General Counsel, Finance,
Medical Public Affairs and others. This
single administrative location aims
to encourage efficiency and eliminate
technological redundancies, while
allowing for serendipitous collisions
and collaborations. New faculty offices
free up space in clinical care buildings,
allowing for expanded patient services.
Integrating safety operations also provides
an additional level of campus security.

CLINICAL CARE
The medical school’s clinical
practice has tripled in size
over the past 15 years. Visits
to the Center for Advanced
Medicine are expected to
continue to grow to 500,000
by 2020. Five floors of the
Center for Outpatient Health
administrative offices have been
moved to the Mid Campus Center
to make way for this increasing
patient volume. This has allowed for
multiple clinical programs to expand,
including additional oncology infusion
bays. The medical school also is working
with hospital partners to improve signage,
valet service, pathways and operations with
the goal of enhancing the patient and
visitor experience.

Spring 2017

AMENITIES
Amenities include: a Kaldi’s Cafe in the Mid Campus
Center, Farmstead cafe serving locally sourced
food in the McDonnell Pediatric Research Building,
and an improved, dedicated space for food trucks,
complete with green space and picnic benches. A new
bookstore in the Mid Campus Center includes a FedEx
kiosk. A larger FedEx facility will open in the Clinical
Sciences Research Building link. Expanded and improved
lactation rooms aim to reduce barriers to breastfeeding
for all new mothers on campus.

STUDENT LIFE
To enhance the student experience and
revitalize historic sites, apartment-style
housing is being built in the original
Central Institute for the Deaf and the
original Shriner’s Hospital. The facilities
will house 197 beds, additional common
space for expanded fitness and recreation
opportunities, a music room and
community center. In this increasingly
digital age, Bernard Becker Library has
removed three floors of stacks to create a
centralized interactive educational hub with
space for education offices and all their affiliated
services. The library also will house the Feuerstein
Health and Wellness Information Center that will
bring together services and resources for students,
faculty and staff.

PAT H WAYS
Plans to improve campus access and safety
include enhancing the Central West End
MetroLink arrival experience with an
extended platform and better pedestrian
circulation routes and adding a new station
east of Boyle Avenue. Already completed:
an elevated walkway link, which now connects
four employee garages to the hospitals and west
part of campus, a new 3,000-space Duncan
Central Garage, defined bike and pedestrian
pathways, additional and clearer signage, and
new traffic signals and turn lanes to make
intersection crossings easier.
Outlook 9
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Gateway
to care

Fighting social stigma and barriers, doctor seeks
to prevent HIV infections worldwide.
BY KRISTINA SAUERWEIN

In Africa, Assistant Professor Rupa
Patel, MD, MPH, meets with team
members from Jhpiego. This nonprofit organization works with Kenyan
governmental leaders to implement
HIV prevention throughout the country.
outlook.wustl.edu

In 1978, during the infancy of the AIDS epidemic, reports
about isolated cases of gay men suffering from a rare lung
infection and an aggressive cancer began trickling in to
the Centers for Disease Control and Prevention (CDC).
That same year, Rupa Patel was born in the Midwest
to immigrants from rural Indian villages. While her
parents worked long hours in medicine and business,
Patel became family mama-bear, a persistent protector
helping her non-English speaking, illiterate grandmother
as well as her little brother — who never quite fit in —
navigate life in white suburban Michigan.
By the time Patel earned a medical degree in 2004,
her brother had acknowledged he was gay, and she
had discovered a passion for treating people who were
emotionally vulnerable, socioeconomically disadvantaged
and at risk for contracting human immunodeficiency
virus (HIV), the virus that causes AIDS.
For Patel, MD, MPH, Washington University
School of Medicine — with its international reputation
for developing HIV/AIDS prevention and treatment
therapies — beckoned. She arrived on campus in
2013 as an instructor of medicine in the Division of
Infectious Diseases.
Outlook 11

I

knew this would be an excellent place for
me to make an impact on the community
as well as in the medical field,” said Patel,
who favors her division’s emphasis on
hands-on research and community outreach.
“Also, importantly, the HIV/AIDS scientists here
are world-renowned.”
Their influential body of work ranges from
research on the potent multidrug AIDS “cocktails”
developed in the 1980s to ongoing analysis of the
relationship between the virus and inflammation
to recent studies on the role of gut microbial
communities in HIV/AIDS. Such efforts have
helped to commute AIDS from a death sentence
that, thus far, has claimed 35 million lives globally
to a chronic and manageable disease, with
treatments that provide a normal life expectancy.
Patel’s mission is to prevent HIV infections
altogether. From urban St. Louis to the rural
Midwest to remote African and Asian villages,
Patel advocates for a once-daily pill called PrEP,
which stands for “pre-exposure prophylaxis.”
Studies have shown that pre-emptive use of this
antiviral drug, when taken consistently, decreases
the risk of HIV infection more than 90 percent. In
illicit drug users who share needles, PrEP is more
than 70 percent effective at reducing risk.
PrEP contains Truvada, which the U.S. Food
and Drug Administration approved in 2012 as
“an important milestone in our fight against
HIV.” The CDC and World Health Organization
(WHO) also endorse PrEP.

GENEVA

INDIA

“PrEP is a game changer for HIV prevention,”
said Patel, director of the PrEP Program at the
Washington University Infectious Diseases Clinic
and a PrEP advisory group member for the WHO.
In her various roles, Patel has helped revise
international PrEP guidelines and consulted for
PrEP programs in places such as Brazil, South
Africa and, most recently, India and Kenya. HIV
rates in these countries are especially high among
teens and young women who work in the sex
industry. “PrEP’s public health implications are
profound,” Patel said.
The CDC estimates that 1.2 million Americans
live with HIV; of those, approximately two-thirds
are not in treatment. Yearly, 40,000 people in the
U.S. receive an HIV diagnosis, but those numbers
have declined about 19 percent since 2005.
However, HIV rates are climbing among
certain populations — in men who have sex
with men and in African-Americans and other
minorities. Reasons include a lack of health-care
access, cultural and social stigmas and an overall
distrust of the medical profession, a particular
problem in the African-American community.
“It is critical to knock down these barriers,”
said Patel, noting that the HIV-infected who are
untreated or undiagnosed are the most likely to
transmit the virus.
Other preventive treatments also are advancing.
Patel, along with Rachel Presti, MD, PhD, the HIV
director of the school’s AIDS Clinical Trials Unit,
and other investigators, are leading a clinical trial
testing an injectable drug that prevents HIV and
only needs to be given every two months.
“Although AIDS is no longer a death sentence,
HIV prevention remains a public health priority,”
said William G. Powderly, MD, co-director of the
infectious diseases division and one of the reasons
Patel wanted to work at the medical school.
“HIV/AIDS is not a situation that is going away
any time soon. In a short period, Rupa Patel
has done a remarkable job establishing PrEP
in St. Louis and globally while also conducting
influential research,” added Powderly, who also

KENYA

BRAZIL
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Rupa Patel, a PrEP advisory group
member for the World Health
Organization, travels around the
globe raising awareness about HIV
prevention.
Spring 2017
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is the J. William Campbell Professor of Medicine
and the Larry J. Shapiro Director of the Institute
for Public Health. “She has become a leading
expert on PrEP.”

Truvada combines two medications — emtricitabine
and tenofovir disoproxil fumarate, both used in
HIV treatment regimes. For people exposed to
HIV, Truvada inhibits virus replication while typically causing minimal side effects.
“It’s a primary prevention strategy like taking
aspirin daily to prevent a heart attack,” Patel said.
Since 2014, Patel has led PrEP clinical trials in
St. Louis with a focus on raising awareness among
primary care physicians and high-risk individuals.
The drug — which costs approximately
$1,500 for a 30-day supply — is covered through
health insurance or financial assistance from
the manufacturer.
Patel sees patients in the Washington
University PrEP clinic on campus and also
monitors patients at a pharmacy-based clinic in
a neighboring strip mall. PrEP patients undergo
quarterly checkups and receive HIV testing.
“PrEP has been called the gateway to primary
care for some at-risk populations. It’s important to
seize this opportunity to connect this group with
other prevention services,” Patel said.
Despite published research acknowledging
PrEP’s effectiveness, the drug is not widely
prescribed. One-third of primary care physicians
and nurses don’t know it exists, a 2015 CDC report
found. PrEP programs are at various stages of
implementation in the U.S., Canada and Australia,
as well as clusters of countries across the globe.
At an international HIV research conference
in 2016, Patel presented an analysis on missed
opportunities for PrEP. Based on surveys of 102
patients in St. Louis, her research found twothirds had asked their primary care physicians for
PrEP but were not prescribed it. The physicians
cited discomfort with discussing the medication,
in part, because they knew little about it.
“Many physicians see PrEP as unnecessary
because they believe their patients can just use a
condom to prevent HIV,” Patel said. “But condoms
are not 100 percent effective. The best scenario is
to use both a condom and PrEP because, together,
the likelihood of contracting HIV is miniscule.”

outlook.wustl.edu
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Serving at home and abroad

1990s

Complex HIV
treatment cocktail

2000s

HIV treatment with
fewer pills

2006

Singletablet HIV
treatment

2012

Singletablet HIV
preventive

2017

HIV preventive
injection every
two months

TOP: Bill Powderly, MD, right, holds an Outlook magazine
cover from summer 2001 featuring his work with the
multidrug “cocktails” then prescribed for patients living with
AIDS. Rupa Patel holds the single daily pill called PrEP that
now can help prevent HIV infections. Bottom: Therapies for
HIV and AIDS have grown increasingly manageable.
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Over the past 30 years,
David B. Clifford, MD, left,
and Lee Ratner, MD, PhD,
have conducted groundbreaking research on
HIV, AIDS and related
treatments.

Moving science forward

Researchers propel AIDS from death sentence to chronic disease

A

s the mysterious AIDS epidemic
gripped the world in the 1980s,
scientists at the School of Medicine
went to work, contributing to
groundbreaking research on HIV,
as well as treatments such as the
highly active antiretroviral therapy,
commonly known as the AIDS
drug cocktails.
In 1985, Lee Ratner, MD, PhD,
the first to sequence HIV while at
the National Institutes of Health
(NIH), joined the School of Medicine
and helped to steer HIV/AIDS
research to prominence.
More than three decades later,
Ratner, the Alan A. and Edith L.
Wolff Professor of Oncology, is
internationally renown for his
research on HIV and AIDS-related
cancers and has been involved in
dozens of clinical trials affiliated
with the NIH’s AIDS Malignancy
Consortium.
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In 1987, Washington University
expanded its research opportunities
by establishing the AIDS Clinical
Trials Unit (ACTU), part of a prestigious
national network known collectively
as the AIDS Clinical Trials Group and
funded by the NIH.
“Since the beginning of the AIDS
epidemic, Washington University
has been a significant, productive
contributor to HIV/AIDS research
and treatment therapies,” said David
B. Clifford, MD, ACTU director and
the Melba and Forest Seay Professor
of Clinical Neuropharmacology
in Neurology. “Research here and
worldwide is leading toward a cure
for AIDS. Not long ago, I would
have thought it improbable. But the
science is moving forward.”
At Washington University’s
ACTU, approximately 20 studies are
underway examining all aspects
of the disease. Clifford is leading
research on whether statins reduce

heart attacks and strokes in HIV
patients, who are more likely to
develop heart disease than people
without the virus. “The study is
looking at starting the drugs earlier
than in the general population for
our HIV patients in an effort to reduce
these complications,” Clifford said.
Former ACTU Director William G.
Powderly, MD, was a key researcher in
evaluating the AIDS cocktail drugs, a
concoction that decreased viral levels
so patients could live longer. More
recently, his research has focused on
understanding long-term side effects
of HIV medications, particularly
metabolic problems such as diabetes,
lipid abnormalities and osteoporosis.
“From a scientific perspective, it
is incredible that over the past 30
years, the AIDS epidemic went from
a deadly disease to a preventable,
manageable and chronic disease,”
Powderly said.
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Talking frankly about sex
Patel never misses an opportunity to discuss
PrEP, said Dave Rueschhoff, 35, one of Patel’s
patients who takes PrEP as “an additional layer
of security regarding HIV prevention.”
Rueschhoff, who helps Patel with PrEP outreach and serves as a member of the community
advisory board for the PrEP injection study, said
Patel has a special talent for connecting with
others. “She is caring and genuinely respects all
individuals,” he said. “Dr. Patel knows her patients’
culture and asks about their lives. She uses
LGBTQ (lesbian, gay, bisexual, transgender and
queer) language to assess risky sexual behaviors.
She is not judgmental about anything people tell
her and that makes them feel comfortable opening
up to her. Talking explicitly about sex does not
faze her.”
Indeed. Patel distributes PrEP flyers everywhere
she can, visits LGBTQ nightclubs and bathhouses
to educate owners about PrEP, advertises on social
media and coordinates community outreach
through events and LGBTQ phone apps.
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More people at high risk for HIV would
take PrEP if they understood it better, said Matt
Swango, 39, a social worker at Saint Louis Effort
for AIDS who works with Patel on PrEP outreach.
“Many people say PrEP has taken the fear out of
sex so they are able to get on with their lives,” he
said. “It’s incredible if you compare it to the 1980s
when people were literally dying in the streets.
Younger people may not realize how far we’ve come
because they’ve always lived in a world with AIDS.”
Critics cite concerns such as PrEP’s lack of
protection against sexually transmitted diseases as
well as its dependence on people remembering to
take a pill every day. There also is fear that PrEP
will increase sexual promiscuity; however, studies
have shown otherwise.
“One of PrEP’s biggest obstacles is a major
reluctance to talk about sexual practices and
sexual health in our society,” Patel said. “Men who
are having sex with men may feel uncomfortable
talking to a physician while physicians do not
always view it as their role to discuss sexual
health. Some never ask about a patient’s sexual
preferences. This is a missed opportunity to
identify a person who may be at risk for HIV.”

Preventing HIV infection:
1. The body can fight off and
destroy most germs (purple)
before they replicate, but
HIV (green) infects immune
cells called T cells. 2. HIV uses
reverse transcriptase to rapidly
copy itself inside the T cell.
The T cell bursts, causing the
virus to spread. 3. PrEP is a
combination of two medications called emtricitabine and
tenofovir disoproxil fumarate,
which are nucleoside reverse
transcriptase inhibitors. These
two medications block the
virus from entering the body’s
immune cells and, thus, prevent HIV infection.

A craving for ice cream recently led Patel to
Boardwalk Waffles & Ice-Cream, a new eatery in a
trendy, LGBTQ-friendly St. Louis neighborhood.
“Can I hang a PrEP information poster here?”
Patel asked co-owner Keith Cotton.
Patel chatted with Cotton about business,
everyday life and PrEP. “I want you to know about
PrEP in case customers see the poster and ask about
it,” Patel said, eating an ice cream waffle.
Patients and colleagues agree that Patel’s
blunt, yet empathetic, approach is a key strength
in helping patients. It’s one she learned before
graduating from medical school. In 1999, her
17-year-old brother came out as gay. “I went to
LGBTQ dance clubs with him and immersed
myself into his world to gain insight into what
he was going through,” Patel said.
“My experience with my brother showed me
how to approach communities at risk for HIV,
de-medicalize or de-stigmatize sexual health, and
create a clinic environment that offers more support
and comfort for individuals.
“Washington University continues to be at the
forefront of ending HIV because its physicians
combine compassion with outstanding research.”
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An Air Force trauma team is
activated at Bagram Air Base
in Afghanistan.
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Battlefield
to bedside
High-intensity military medicine spurs
innovations for civilians, too.
BY REBECCA BOYLE

In a war zone in Afghanistan, a roadside bomb explodes
and shrapnel tears through a U.S. soldier. The blast
hurls him to the ground, and blood begins to flow
from multiple wounds.
The soldier described here — a composite based on
actual cases — faces a terrifying prospect: losing too
much blood to survive before making it to a medical
center. Bleeding out is the leading cause of potentially
survivable deaths on the battlefield.
In this sandblasted combat setting, military medics
must race to slow the bleeding and get the soldier to
better-equipped facilities. To do this, they lean on skills
they learned more than 7,000 miles away at Washington
University School of Medicine prior to deployment. Their
efforts are the first step in a long chain of military actions
that ultimately will bring the injured war fighter home.
Surgeons and researchers here are training military
medics in frontline readiness, inventing ways to control
and replace blood loss, and shaping U.S. military-civilian
trauma care policies. These efforts are positioning St. Louis
as a national hub for research and control of traumatic
bleeding, which could save not only lives like the soldier’s,
but that of civilians, too.
outlook.wustl.edu
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W

hen the wounded soldier in
Afghanistan is stable enough to
move, a helicopter flies him to
the next triage station: a tent hospital with
equipment stored in canvas bags for easy
transport in an emergency.
Doctors invoke a “walking blood bank,”
and military personnel pre-screened for blood
donation rapidly assemble. Within 30 minutes,
one unit of whole blood is collected, and then
transfused to the patient, while a surgical team
works to control the bleeding.

Pre-deployment
trauma training
Before entering the war zone, many of these
medical practitioners were trained in situations
that mimic battlefield conditions — and they did
it in St. Louis. The School of Medicine is the
newest partner, along with the U.S. Air Force
and SSM Saint Louis University (SLU) Hospital,
in a national program called the Center for
Sustainment of Trauma and Readiness Skills
(C-STARS).
In C-STARS, military medical technicians,
nurses and doctors undergo 19 two-week
sessions yearly at one of five national training
sites. Covered topics include: care under fire,
pre-hospital triage, hemorrhage control and the
particulars of air evacuation. In short, medics
are trained to use the latest field-ready
innovations to sustain life.
When these physicians and medics are not
deployed to a war zone, they may work in private
practice or be reservists on military bases in the
U.S. Their daily work typically is nothing like a
war hospital. Yet, next year or the year after, they
may get redeployed and thrown into situations
Col. Gerald Fortuna, MD, director of the C-STARS
program and a vascular surgeon at the medical
school, leads a REBOA training exercise. Developed
by the military, REBOA (Resuscitative Endovascular
Balloon Occlusion of the Aorta) is a relatively new
blood-control technique only available at a handful
of medical institutions. Using an ultrasound wand,
trauma medics can guide placement of a catheter
into the femoral artery and inflate a balloon to
block the blood vessel. That way, a patient’s heart
can still pump blood to the brain, without pumping
it out of the open wound.
18 Washington University School of Medicine
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“But there are things we do that are going to help
them. It’s an exchange. It really is a partnership.
“These are women and men who put their lives
on the line, and develop the casualty programs
that take care of our troops. If we can help in
keeping their skill levels at the highest level, well,
that’s a way for us to give back, frankly.”

How to save a life
As part of the care continuum, the wounded
soldier in Afghanistan is moved again — from
the austere tent to a Combat Support Hospital at
Kandahar Air Base.
After another surgery, he flies on a cargo plane
to Landstuhl, Germany, home of the only Level
1 trauma center not on U.S. soil to be certified
by the American College of Surgeons. The next
day, teams of medics and military workers ready
the soldier for his flight across the Atlantic
Ocean. Injured U.S. troops ultimately are sent to
Walter Reed National Military Medical Center in

TIM PARKER

where they need to be at the top of their game.
“It’s easy for skills to erode if you spend too
much time at your home base,” said Col. Gerald
Fortuna, MD, director of the St. Louis C-STARS
program and a vascular surgeon newly recruited
to the School of Medicine. He holds joint
appointments at Washington University and Saint
Louis University.
“Back at home, the No. 1 surgical procedure in
our hospitals is delivering babies,” he said. “That’s
drastically different than being over in Iraq or
Afghanistan, where we’re seeing traumatic amputees,
burns, multiple high-velocity gunshot wounds.
When we go downrange,” — military term for
deployment — “everything gets turned upside down.”
Washington University’s partnership with
C-STARS ensures new training opportunities
in this arena, even as the armed forces wind
down their involvement in countries such as
Afghanistan and Iraq, Fortuna said.
While St. Louis’ busiest hospital — BarnesJewish — is no battlefield, the principles of highintensity emergency medicine are the same, said
Timothy J. Eberlein, MD, the Bixby Professor of
Surgery and head of the Department of Surgery.
Barnes-Jewish cares for about 13,000 trauma
patients each year, with a 99 percent survival rate.
“Not many of us get exposed to high-percussive
bombs and armor-piercing bullets like our troops
do,” Eberlein said. “But it’s the principles that we
all benefit from: How do you stem blood loss?
How do you treat the person who has had multiple
traumatic injuries? How do you quickly get them
out of the field and into a triage of care, in a
stepwise progression?”
St. Louis is the oldest C-STARS site, established
15 years ago in partnership with SLU. With
Washington University’s entry into the program,
C-STARS can leverage the medical school’s many
strengths, Eberlein said. Training now takes place
on both campuses, and Washington University has
plans to recruit more emergency physicians and
trauma surgeons in connection with the program.
Eberlein added that the medical school has
a long track record of translational research
on acute and critical care, trauma surgery and
cooperation with the U.S. Defense Department,
plus a strong research program focused on
traumatic bleeding.
“C-STARS brings concepts from the military
that we can adapt, and it makes Washington
University and the Department of Surgery better,”
said Eberlein, who lobbied for the collaboration.

Timothy J. Eberlein, MD, center, head of the Department of
Surgery, leads a cohort of military personnel on a tour of the
Medical Campus. Above, Maj. Gen. Robert D. McMurry Jr.,
left, and Brig. Gen. Mark A. Koeniger.
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During Operation Iraqi
Freedom in Baghdad,
critical care doctor Phil
Spinella, MD, right, first
became interested in
the efficacy and safety
of blood products for the
treatment of shock.

Bethesda, Maryland; Brook
Army Medical Center in San
Antonio; or Balboa Naval
Medical Center in San Diego.
“With the whole operation
running, it would not be
uncommon for somebody to
be injured on the battlefield
and wake up in 72 hours
in the U.S., having received
three, four or five operations
in that time,” said Fortuna,
who served two tours of duty
in Afghanistan. It’s one reason
why, in the most recent conflict in Afghanistan and
Iraq, the U.S. armed forces experienced the lowest
case fatality rate in the history of modern warfare,
he said.
“If you made it off the battlefield, and made it
to that tent hospital with a surgeon, your survival
rate was over 98 percent. We were actually
exceeding civilian hospitals, and with a higher
acuity level,” Fortuna said.
It wasn’t always this way. Almost one-fourth of
Americans who died in conflict during the past
decade perished from wounds they might have
survived given the proper care, according to a
report from the military’s Joint Theater Trauma

System. This finding led the secretary of defense to
impose standards for pre-hospital transport times
in an effort to reduce death from severe bleeding.
Hemorrhagic shock is defined as a loss of more
than 20 percent of the body’s blood supply. At its
most basic level, bleeding occurs because blood
vessels have ruptured. Injury, surgery, childbirth,
infections and cancer therapy all can cause or
promote serious bleeding. In the U.S., about
30,000 people die each year from preventable
conditions after their initial injury, often due to
inadequate therapies or untimely access to care.
If physicians can stop this bleeding, seal torn
vessels and replace lost blood, they can save a
person’s life. Washington University researchers
are searching for novel ways to do this, including
improved blood products, artificial blood and
blood-clotting mechanisms.

The case for whole blood
During Operation Iraqi Freedom in 2004, critical
care doctor Phil Spinella, MD, and his Army
colleagues couldn’t wait any longer for blood supplies
to arrive in Baghdad. They rolled up their sleeves
and gave their own blood directly to the casualties.
Surprisingly, it worked better; hemorrhagic shock

“It’s not intended to replace
human transfusion, but to push
transfusion capability into more
austere settings.”
— Allan Doctor, MD
FROM THE COVER ErythroMer is a red blood
cell substitute formulated from purified hemoglobin.
A polymer coating is “immune silent,” so anyone can
accept the artificial cells regardless of blood type.
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resolved sooner in patients
receiving whole blood versus
separated blood components
(platelets, red blood cells and
plasma) shipped from home.
“When you take blood and
split it into components, it’s
much more diluted. That affects
blood’s ability to stop bleeding
and to carry oxygen,” said
Spinella, who served as activeduty Army for 12 years, earning
the Bronze Star and Combat
Medic Badge for providing care
under fire.
It was during this
deployment that Spinella
became interested in the efficacy
and safety of blood products for
the treatment of shock.
Today, he is director of
the Pediatric Critical Care
Translational Research Program at St. Louis
Children’s Hospital, director of the Blood Research
Program and professor of pediatrics. He studies
transfusion outcomes in children and adults with
severe bleeding and the effects of red blood cell
storage times on recovery.
Based on research and testimony provided by
Spinella, the U.S. surgeon general issued changes
supporting increased ratios of both plasma and
platelets to red blood cell units for military
casualties with severe hemorrhage.
Nationally, Spinella has been a vocal advocate
for trauma care improvements. As part of a
National Academy of Sciences committee, he
helped write a 400-page report to ensure that
lessons learned from the military’s experiences
in Afghanistan and Iraq are integrated into
future combat operations and into the civilian
trauma system.
And following the Boston Marathon bombing
and resulting concerns about inadequate blood
supplies in the wake of terrorist attacks, Spinella
organized a full-day conference at the White
House for the National Security Service. Spinella
said he felt it was important to expose the fact
that all major U.S. cities are at risk of running
out of blood in any mass-casualty event. Most
emergency preparedness efforts focus on
evacuations, he said, not on the blood supply.
He advocates a whole-blood program in which
pre-screened donors could be alerted to report
to U.S. collection centers.
outlook.wustl.edu

Substitutes for real blood
For more than 80 years, researchers have searched
for artificial blood substitutes. The need is clear:
in acts of mass violence, on the battlefield and in
remote locations. Now, the School of Medicine is
on the forefront in developing them.
Researchers here believe that red blood cells
— in a powdered form — might be available to
trauma patients within 10 years. This powder
could be stored in a backpack for a year or more
and reconstituted with water when needed. By
contrast, fresh blood can be stored for about 40
days. Unrefrigerated, it only lasts a few hours.
Allan Doctor, MD, professor of pediatrics,
immediate past director of the Division of
Pediatric Critical Care and associate professor of
biochemistry and molecular biophysics, worked
with Spinella, Gregory M. Lanza, MD, PhD, the
Oliver M. Langenberg Distinguished Professor of
Science and Practice of Medicine, and Dipanjan
Pan, PhD, (now at the University of Illinois at
Urbana–Champaign) to create an artificial red
blood cell that can pick up oxygen and transport it
through the body, as a human red blood cell does.
The artificial cells, called ErythroMer, are made
from purified hemoglobin, the oxygen-transporting
component of red blood cells. The cells are freezedried into a powdered form. A polymer coating

Allan Doctor, MD, left, lead
developer of ErythroMer, and
research specialist Shivam Shah
compare the vascular reactivities
of artificial and real red cells.
Emulating red cell physiology
is a novel, unique feature
distinguishing ErythroMer
from other blood cell
substitutes.
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Clot control

Tissue sealer

Rapid clotting

Blood substitute

Innovations in blood control and replacement
New options buy time, increase the odds for trauma patients
EVARREST® Fibrin
Sealant Patch
EVARREST contains two
human biological components:
fibrinogen and thrombin.
When applied to a bleeding
area, moisture causes the
substances to react together,
leading to rapid clot formation.
In about eight weeks, the body
absorbs the patch material.
EVARREST does not require
preparation, mixing, moistening
with saline or refrigeration, and
has a shelf life of 30 months.

TAMPITI trial

ClotFoam®

ErythroMer

Tranexamic acic, or TXA, reduces
the breakdown of clots that
form with bleeding and has been
shown to minimize blood loss
in patients with hemophilia,
a genetic clotting disorder.
Researchers are evaluating
the drug’s safety and optimal
dosage in trauma patients.
Patients who require at least
one unit of blood or immediate
transfer to an operating room
are eligible for the trial.

ClotFoam might help in cases
in which a patient is bleeding
so badly that compression of
the wound doesn’t help, in the
operating room and on the
battlefield. When mixed and
injected, the adhesive hydrogel
spreads throughout the body
cavity, sealing lacerated tissue
and promoting clotting. The
product’s technology generates
a 3-D scaffold that carries a
fibrin sealant.

This nanoparticle-based red
blood cell picks up oxygen from
the lungs and detects where it
should be delivered based on
the pH level of the blood. The
cells are made from purified
human hemoglobin and coated
with synthetic polymer. As
hemoglobin can cause blood
vessel constriction — increasing
the risk of heart attack and
stroke — the coating is a key
differentiator to past attempts.
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Stopping the bleeding
Washington University researchers also are
involved in a variety of blood-clotting innovations.
Spinella and Grant Bochicchio, MD, MPH,
the Harry Edison Professor of Surgery and chief
of the Section of Acute and Critical Care Surgery,
are studying the use of a tranexamic acid, a
blood-clotting drug that could improve survival.
The trial, Tranexamic Acid Mechanisms
and Pharmacokinetics in Traumatic Injury
(TAMPITI), received the first consent exemption
ever granted by the School of Medicine’s
Institutional Review Board. Patients who arrive
at Barnes-Jewish Hospital with traumatic injuries
requiring transfusion are automatically placed
in the trial, and informed that they received the
drug after they are stabilized.
Sometimes a drug might not be enough to
help clot a wound; in that case, the FDA-approved
EVARREST patch could help. It looks like ordinary
cotton gauze, but the patch contains blood-clotting
agents, so it not only seals a wound, but also actively
works to stop blood from flowing, explained
Bochicchio, who was involved in the development.
In addition, use of specialized foam to stop severe
internal bleeding due to trauma is a step closer to
reality, largely through Bochicchio’s efforts.
He is principal investigator of a phase I
clinical trial evaluating the safety of ClotFoam.
The foam, administered via an applicator device
during surgery, binds to the bleeding site and
fills the body cavity.
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“That way, you can get the patient to a surgeon
further afield. It’s kind of like ‘fix-a-flat’ technology,
if you will,” he said. Bochicchio also has worked
at the R. Adams Cowley Shock Trauma Center in
Baltimore, which is another C-STARS center.
Bochicchio and colleagues already have
established the foam’s effectiveness in animals;
their clinical trial evaluates safety and
effectiveness in humans.
In the future, a wounded soldier like the one
in Afghanistan might face better odds because
of technology and protocols developed or tested
in St. Louis — from a transfusion of ErythroMer
or whole blood, to the EVARREST patch and
ClotFoam, to seamless triage and transport.
While all these changes would improve a
wounded war fighter’s chance of survival, the
truth is that these advances benefit civilians, too.
Spinella said all types of patients could have better
outcomes — adults and children alike, trauma and
surgical patients and those with internal bleeding.
“This affects everybody, no matter who
you are.”

ROBERT BOSTON

is “immune silent” so anyone can accept the
powdered blood cells regardless of blood type.
Of course, red blood cells perform many
functions beyond carrying oxygen. Artificial
blood never will replace the real thing, but it
can buy critical time for a wounded patient.
“It’s not intended to replace human
transfusion, but to push transfusion capability
into more austere settings,” Doctor said.
Clinical trials in small animals already have
shown success, and the researchers are moving
into larger animal studies.
The researchers’ vision extends beyond the
battlefield. Such a substitute could be stored
where people congregate — in stadiums, malls
and other public venues that might fall under
large-scale terrorist attacks.

Grant Bochicchio, MD, MPH, and a colleague assemble the device
used to apply a specialized foam to control severe bleeding in
trauma patients. Bochicchio is heading a clinical trial testing its
safety and effectiveness in humans.
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CHILD NEUROLOGY

Jordan Cole
PEDIATRICS

Ari Berlin
Miquia Henderson
Amanda Reis
Ellen Schill

Saint Louis University School
of Medicine
OBSTETRICSGYNECOLOGY

Bree Porcelli
RADIOLOGYDIAGNOSTIC

Alisa Tanakit
Francis Wu

Washington University
OPHTHALMOLOGY

Jennifer Enright

NEW JERSEY

Rutgers-New Jersey
Medical School

GENERAL SURGERY

Arith Ruth Reyes

NEW YORK

Hofstra Northwell School
of Medicine
DERMATOLOGY

Jacobi Medical Center/Einstein
College of Medicine
PEDIATRICS

Rachel Stern

Memorial Sloan Kettering
Cancer Center
RADIATION ONCOLOGY

Ishita Chen
Xiaojing Huang

Montefiore Medical CenterEinstein Campus
INTERNAL MEDICINE

Nai Chien Yeat
OBSTETRICSGYNECOLOGY

Asante Badu
RADIOLOGYDIAGNOSTIC

Sean Boone

New York Presbyterian
Hospital-Columbia University
Medical Center
PEDIATRICS

Carol Shen

NORTH CAROLINA

Duke University Medical Center
ANESTHESIOLOGY

Rosie Tang
INTERNAL MEDICINE

Daphne Xiao
MEDICINEPEDIATRICS

Austin Wesevich

University of North Carolina
Hospitals
ORTHOPAEDIC SURGERY

Karly Lorbeer

OHIO

Cleveland Clinic Foundation
ANESTHESIOLOGY

Shari Oesterreich

Ohio State University
Medical Center
EMERGENCY MEDICINE

Christine Luo

University of Cincinnati
Medical Center
OTOLARYNGOLOGY

Sonia Yuen

P E N N S YLVA N I A

Albert Einstein Medical Center
EMERGENCY MEDICINE

Elizabeth Rosenberg

Allegheny General Hospital
EMERGENCY MEDICINE

Anna Moseley
Emily Moseley

Children’s Hospital of
Philadelphia
PEDIATRICS

Ashley Osborne

Hospital of the University of
Pennsylvania
EMERGENCY MEDICINE

ORTHOPAEDIC SURGERY

Agnes Dardas

Thomas Jefferson University
ORTHOPAEDIC SURGERY

Brandon Rogalski

University of Pittsburgh
Medical Center
INTERNAL MEDICINE/ABIM
RESEARCH PATHWAY

Edwin Chen
Sunmin Park
PEDIATRICS

Chinwe Madubata

TENNESSEE

Vanderbilt University
Medical Center
OBSTETRICSGYNECOLOGY

June Wang

TEXAS

Baylor College of MedicineHouston
ORTHOPAEDIC SURGERY

Aalok Patel
PEDIATRICS

Alejandro Siller

University of Texas Medical
School-Houston
UROLOGY

Nathaniel Coddington

University of Texas Southwestern
Medical Center
INTERNAL MEDICINE

Ethan Tobias
OBSTETRICSGYNECOLOGY

Kelly Milman

WASHINGTON

University of Washington
Affiliated Hospitals
OBSTETRICSGYNECOLOGY

Nicole Kretzer
PEDIATRICS

Lucy Bollinger
Jennifer Duong
PLASTIC SURGERY
INTEGRATED

Jenny Yu

WISCONSIN

Mayo Clinic School of
Graduate Medical Education
FAMILY MEDICINE

Jared James

Medical College of Wisconsin
Affiliated Hospitals
PLASTIC SURGERY
INTEGRATED

Miles Bichanich

University of Wisconsin
Hospital and Clinics
OBSTETRICSGYNECOLOGY

Melissa Meyer

CANADA

Amy Xu

Rachel Gartland
Gregory Rippberger

University of Calgary

ORTHOPAEDIC SURGERY

INTERNAL MEDICINE

Michael James

Hospital for Special Surgery
Tony Shen

Icahn School of Medicine at
Mount Sinai
OBSTETRICSGYNECOLOGY

Lindsay Burton

Abraham Segura

ORTHOPEDIC SURGERY

MEDICINEPEDIATRICS

Kenneth Macneal
NEUROLOGY

Jessica Fan

Choosing to defer residency:
Paul Gamble
Arthur Lee
Tara Rao

See more photos online:
wumcnews.org/match2017
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Caring
for mom
& baby
BY HILARY DAVIDSON

Children’s outcomes
improve when perinatal
mental health issues are
addressed.

R

obin Torrence-Webber was thrilled when,
at 37, she became pregnant with her second
child. But a diagnosis of preeclampsia and

an emergency caesarian section at 23 weeks presented
a difficult reality. Babies generally are not considered
medically viable before 24 weeks of gestation.
She woke to learn that her newborn son, Baby Ray
Webber III, who weighed just 1 pound, 1.6 ounces,
had been taken from Barnes-Jewish Hospital to
St. Louis Children’s Hospital, where doctors were
trying to save his life.
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From left, Robin TorrenceWebber with her son, Baby
Ray, and therapist Anna
Constantino-Pettit, MSW ‘14.
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Three days later, Torrence-Webber finally got to see her
baby. “He was so little,” she said. “He could literally fit in
the palm of my hand.” Torrence-Webber spent days and
nights at the neonatal intensive care unit (NICU),
not knowing if her son would survive.
While Ray clung to life, Torrence-Webber grew more
anxious and depressed. She was torn between taking care
of her daughter at home and visiting Ray in the NICU.
“I was having anxiety attacks,” she said. “I couldn’t
sleep. I couldn’t function.”
Torrence-Webber sought help after NICU staff told her
about the Perinatal Behavioral Health Service (PBHS) at
the School of Medicine. The PBHS offers counseling and
psychiatric care for pregnant women and new mothers
with anxiety or depression.

Fifteen percent of women experience perinatal anxiety or
depression. Although women with a history of psychiatric
disorders are predisposed to the condition, it can strike
anyone. For women with babies in the NICU, the number
jumps to 40 percent. Parents of babies in the NICU
undergo enormous stress and often face unaddressed
mental health issues.
Cynthia Rogers, MD, one of the PBHS founders,
determined that by setting up services to treat these
mothers, she could improve the outcomes of their children.
Rogers, an assistant professor of child psychiatry, has
studied how exposure to a parent with behavioral health
issues affects brain development in young children,
increasing the likelihood of childhood psychiatric disorders.
Left untreated, such issues can affect a child physically
and emotionally, beginning in the womb. Studies suggest
that the mother’s physiology during pregnancy can change
the baby’s physiology.
Elevated levels of the stress hormone cortisol, common
in depressed patients, are believed to affect development of
a part of the brain called the amygdala. Other research has
revealed differences in the thickness of the cerebral cortex
between infants of depressed mothers and a control group.
Behaviorally, such infants are at increased risk for fussiness,
failure to thrive, and developmental delay at 1 year of age.
Mental health issues also affect how moms are able to
care for and interact with their children. “Mothers with
untreated mood disorders are less likely to engage in a
host of nurturing behaviors proven to promote healthy
development and attachment, including breastfeeding,
being emotionally responsive and affectionate, reading,
and singing to babies,” Rogers said.
Moreover, studies have shown that children whose
parents have untreated mental health issues are at much
greater risk to experience abuse and neglect. As they grow,
outlook.wustl.edu
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Physical, emotional toll on baby

Cynthia Rogers, MD, right, co-founder of the Perinatal Behavioral Health Service,
discusses the progress of infant Tycen Reisch with his mother, Stacy Reisch.

these children are more likely to develop mental issues such
as depression and attention deficit/hyperactivity disorder.
“When you don’t treat moms, you see a significant
impact on child mental health, academic performance
and many other outcomes,” Rogers said.

Serving a critical need
Rogers began treating parents of NICU babies in 2010
— first by meeting them in the NICU, and later via a
Children’s Hospital clinic. She realized, over time, that these
families needed more help than she alone could provide.
As a child psychiatrist, Rogers’ schedule already was full.
At the same time, Kelly Ross, MD, assistant professor
of pediatrics, was searching for a way to help anxious
and depressed mothers who had delivered babies at
Barnes-Jewish.
Rogers and Ross joined forces to create the Perinatal
Behavioral Health Service in 2012. They chose the term
“perinatal” rather than “postpartum” because the PBHS
works with both new mothers and pregnant women, who
are also at increased risk for depression.
Supported by grants and private philanthropy, the
PBHS is a team of social workers, psychiatrists and
psychologists who offer testing, counseling, medication
and case management.
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Learning to adjust
Torrence-Webber developed coping skills through
weekly sessions in the NICU with PBHS therapist
Anna Constantino-Pettit, MSW ’14. “Anna lifted
my spirits,” she said.
Talking to Constantino-Pettit helped ease TorrenceWebber’s guilt as she split her time between Baby
Ray and family at home. At her therapist’s suggestion,
Torrence-Webber began meditating and writing in a
journal. Constantino-Pettit also taught Torrence-Webber
to be mindful of situations that trigger negative feelings.
Perhaps most importantly, Constantino-Pettit
provided Torrence-Webber a safe space to talk about
her difficulties without being judged.
At 8 months of age, Baby Ray was ready to come home.
Despite much progress, his homecoming presented new
challenges. “I went from having 24-hour nursing care
to taking care of a baby who’s on oxygen and a heart
monitor,” Torrence-Webber said.
Once again, Torrence-Webber realized she needed
help to adjust to the new routine. She and ConstantinoPettit resumed their sessions. Today, Torrence-Webber
has successfully adjusted to caring for Baby Ray.
Hundreds of families have been helped through the
PBHS, and Rogers remains passionate about its mission.
“Seeing parents who, even after a difficult start,
are raising emotionally healthy children is the most
worthwhile outcome I can think of,” she said.
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Gift strengthens services
for high-risk families

O

ne St. Louis couple with firsthand knowledge of
postpartum depression is boosting the efforts of the
Perinatal Behavioral Health Service (PBHS). Mary Steward and
David Steward II are committed to helping mothers and babies
get off to the best possible start.
With a generous
gift from the Steward
Family Foundation,
the couple created
the Steward Family
Perinatal Behavioral
Health Service Fund
to provide necessary
support. The gift helps
high-risk families that
might not otherwise
have access to mental
health resources. At
Barnes-Jewish Hospital, Mary and David Steward
for example, many
expectant moms are uninsured or on Medicaid.
The Stewards learned about the PBHS while touring the
medical school. They immediately were struck by how early
intervention can translate into lifelong benefits for
moms and their kids.
“We like the proactive aspect of the service,” said Mary
Steward. “It’s not waiting around for something awful to
happen, but getting women help on the front end.
“To not allow someone to be lifted out of that state and
have a great experience with her child because she doesn’t
have access to proper medical care or prescriptions — we
just can’t allow that to happen,” she added.
The subject hits close to home: Mary Steward recalls the
exhaustion and isolation she felt several weeks after the
birth of her first child. Whether her depression was caused by
hormonal changes, being cooped up during a bleak winter, or
the transition to full-time motherhood, she said she knew that
something was wrong.
“It was apparent that it wasn’t just the normal ‘I just
had a baby and I’m a little tired from getting up in the middle
of the night,’” Mary Steward said. She confided in loved ones,
who encouraged her to seek medical care. The treatment
was effective, and, in talking openly about the problem, the
Stewards realized that so many others are affected.
“We hope that our support will help make programs like
this the standard of care,” David Steward II said. “It’s so
important that women across cultures realize that this is a
common condition that can be treated.”
ROBERT BOSTON

The service screens women for anxiety, depression and
trauma at multiple locations, including the maternity
floors at Barnes-Jewish, the NICU at St. Louis Children’s
Hospital, and the Obstetric Clinic at the Barnes-Jewish
Center for Outpatient Health. The service also accepts
community and self-referrals.
In Missouri, obstetrician-gynecologists commonly screen
new mothers for depression at the six-week postpartum
checkup. Because mental illness can affect a mother’s ability
to bond, PBHS screenings take place as early as eight weeks
of pregnancy — potentially improving those first motherchild interactions. Rogers said women need to understand
that mental health issues, such as anxiety and depression,
occur commonly in pregnancy and in those often-grueling
months after bringing home a newborn.
Screening is particularly important because, all too often,
mothers of newborns are afraid to admit they are unhappy.
“Everybody believes that the experience of childbirth
is supposed to be an ecstatic experience,” Rogers said.
“So when that doesn’t happen, women feel that there is
something wrong with them, or that they’re bad mothers.”
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Needed: 500 alumni

Take the Warren Challenge and transform the lives of medical students

I

n gratitude for financial support and training

opportunities that Bob Warren, MD/PhD ’78, MPH,
received at the School of Medicine, he and wife Nancy
Warren, PhD, are challenging fellow alumni to give
back to Washington University. The couple has issued
a $500,000 William Greenleaf Eliot Society Challenge
dedicated to scholarships.
The challenge continues a long tradition of alumni
helping future students. Scholarships and financial aid
enable Washington University School of Medicine students
to graduate with average debt of $97,000 — well below the
national average of $180,000.
“If we can encourage 500 people to join us, together we
can make a significant difference in the lives and careers of
medical students,” said Bob Warren.
“Nancy and I have been members of the Eliot Society for
many, many years. We’re delighted that we can now help
more than we ever imagined with an additional estate gift.
We hope alumni will accept our challenge and join us now
as members of the Eliot Society, and also consider becoming
Washington University Brookings Partners with an estate gift.”
All unrestricted gifts to the university of $1,000 or more
qualify the donor for membership in the Eliot Society. Eliot
Society donations support scholarships, student assistance
programs, educational resources, faculty development and
recruitment, and other initiatives.
The challenge runs through June 30, 2018, the conclusion
of Leading Together: The Campaign for Washington University.
“We want our fellow alumni to reflect upon what their
experiences in medical and graduate school at Washington
University have meant to them and their families,” Bob
Warren said. “The extraordinary medical education
I received catalyzed my professional life,” he added.
“The financial support Bob received while he was in
the Medical Scientist Training Program and I was getting

THE GOAL

my doctorate in psychology
from Saint Louis University
was transformative,” said
Nancy Warren.
In particular, being free
from medical school debt
enabled the pair to pursue
careers in academic medicine.
In his roles as division chief
of pediatric rheumatology and
immunology at the University of
North Carolina at Chapel Hill
(UNC) and as chief of pediatric
Robert and Nancy Warren
rheumatology at Baylor
College of Medicine in Texas,
Bob Warren trained hundreds of physicians in the rare
specialty of pediatric rheumatology. He also championed
caring for chronically ill children via a team approach, which
included family members and other health-care practitioners.

“The financial support Bob
received ... was transformative.”
Similarly, while on the faculties of both UNC and Baylor,
Nancy Warren developed transition programs to help family
members cope with crises or a loved one’s mental illness.
In addition to treating patients, Nancy now teaches at the
Medical University of South Carolina in Charleston.
Bob Warren is still focused on quality of care, but mostly
from a different angle. He is now the chief medical information
officer at the Medical University of South Carolina. He
continues to see children with rheumatic diseases.
Reflecting on their path, Bob and Nancy Warren want to
support and transform the lives of young doctors in the same
way they were helped.

Eliot
Society

Brookings
Partners

500 new or upgraded
memberships

Through bequests or
planned gifts

outlook.wustl.edu

For information on establishing a scholarship at
the School of Medicine, contact Medical Alumni
and Development at (314) 935-9686 or

medicalannualfund@wustl.edu.
To give securely online, visit

medicalalumni.wustl.edu/give.
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classnotes
Find your friends.
Classnotes are organized first by
year of degree/training completion
and then in alphabetical order.

How about you?
Share your news via the online
form at wumcnews.org/classnotes.
Submissions will be printed in
a subsequent issue of Outlook
magazine as space allows. Photos
are welcome.

1960 S
Curtis J. Krock, HS 65, retired from
full-time pulmonary practice in 2001. He
served with the medical residency program
at Carle Foundation Hospital in Urbana, Ill.,
until 2003 and, as interim chief of medicine
at the University of Illinois at UrbanaChampaign College of Medicine until 2005.
Krock enjoys spending winters in
San Francisco.

1970 S
Toby L. Simon, MD 70, is senior medical
director at global biotherapeutics firm CSL
Behring and on the voluntary faculty at the
University of New Mexico School of Medicine.
He recently completed a four-year term as
industry representative for the FDA Blood
Products Advisory Committee. He is also
senior editor of the recently published fifth
edition of “Principles of Transfusion Medicine.”
Robert Weiss, MD 74, returned to Uganda
for a second year of teaching, this time to
Mbale, a city in Eastern Uganda. He is at a
newly established university, teaching its first
fourth-year (clinical) class. His wife is accompanying him as an assistant librarian at the
university. Weiss retired from office practice
with Cleveland Clinic in December 2015.
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1980 S
Linda R. Struckmeyer, OT 82, recently
earned a PhD in occupational therapy from
Texas Woman’s University and was promoted to clinical assistant professor in the
Department of Occupational Therapy at the
University of Florida.
Ellis J. Neufeld, MD/
PhD 85, has been
appointed clinical
director, physicianin-chief and executive vice president
of St. Jude Children’s
Research Hospital,
based in Memphis.
In this role, Neufeld oversees the organization’s academic clinical departments and
all clinical operations. Neufeld previously
served as associate chief of the Division
of Hematology/Oncology at Dana-Farber/
Boston Children’s Cancer and Blood

Disorders Center. He also was medical
director at the Boston Hemophilia Center
and held the Egan Family Foundation Chair
in Transitional Medicine at Harvard Medical
School as a professor of pediatrics.

1990 S
Gary Steven Solomon, LA 92, OT 93, is
president of the American Society of Hand
Therapists. He is manager of Chicago Metro
Hand Therapy and works as a certified hand
therapist. Solomon lives in Deerfield, Ill., with
his wife Debbie (nee Handler), LA 93, OT
94, and their two daughters, Ilana and Talia.
Bernadette Aulivola, MD 97, was
appointed director of the Division of
Vascular Surgery and Endovascular Therapy
at Loyola University Medical Center in
Maywood, Ill., this past July.
Parveen Chand, HA 98, has served as the
chief operating officer at Indiana University
Health-Academic Health Center, Adult
Hospitals, in Indiana since August 2016.

Beloved former professor turns 100

T

he second physician to complete
a residency within the School of
Medicine’s Division of Urologic
Surgery (in 1949) celebrated his
100th birthday in March.
Robert Royce, MD ’42, HS ’49, was
on the medical school faculty for 45
years, including a three-year stint as
head of the urologic surgery division
and 15 years leading its residency
program. Teaching, Royce said, was
one of the great joys of his career.
To honor his legacy as a beloved
professor, in 2010, the division
created the Robert Killian Royce, MD,
Distinguished Professorship in Urologic
Surgery. Gerald L. Andriole Jr., MD,
holds the professorship.
Although retired from medicine for 25 years, Royce remains active. Among his
favorite pastimes: riding an all-terrain vehicle on his ranch, golfing, hiking, playing
poker and spending time with friends, children and grandchildren. “I can’t believe I’ve
been so lucky,” he said. “I’ve had a heck of a lot of fun in my life, and I’m still having fun.”
Royce lives in St. Louis.
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OT honorees

Leanne Lin, MD 15, GM 13, a radiology resident at the University of
Kentucky in Lexington, competes
in powerlifting.

T

Her current stats:
SQUAT — 215 pounds
BENCH — 140 pounds
DEADLIFT — 270 pounds

Alum co-founds online tutoring company

W

hile earning an MD/PhD from the School of Medicine,
Leonid Shmuylovich co-founded Virtual Nerd LLC, an
online tutoring company. As a passionate, part-time tutor
eager to reach even more students, he began recording video
explanations of common trouble topics and sharing them online.
He then partnered with industrial designer Josh Salcman to
further enhance the platform. Virtual Nerd was developed as a
supplemental learning resource, with a focus on middle school
and high school mathematics. Eventually, the pair sold the business to Pearson,
the world’s leading education company, and helped develop Pearson’s awardwinning Mobile Math App.
Shmuylovich, MD/PhD ’15, is now a second-year dermatology resident at BarnesJewish Hospital. He also completed an internship in pediatrics at St. Louis Children’s
Hospital, where he received the James P. Keating Outstanding Resident Award.
Shmuylovich and his wife, Ilana Rosman, MD ’08, assistant professor of
dermatology and pathology, live in St. Louis with their two children.

He lives in Indianapolis with his wife,
Dianne, and 13-year-old son, Cameron.
Their daughter, Amy, lives in St. Louis with
her husband, Richard.
Michael Finley, PhD 98, started a new
position as principal scientist in research and
development at Janssen Pharmaceutical
Companies of Johnson & Johnson in Spring
House, Pa.
David A. Dorr, LA 94, MD 99, was promoted
to professor at Oregon Health & Science
University, where he studies how to use data,
information and knowledge to improve
systems for vulnerable populations. He is
married to Gabrielle Meyers, an oncologist.
The couple has two daughters, ages 5 and 8.
outlook.wustl.edu

Katherine Nowak, PT 99, EMBA 07,
became vice president for care management
informatics and business support for Mercy,
based in Chesterfield, Mo., in August 2016.
She assumed the role of Missouri regent
for the American College of Healthcare
Executives in March 2017.

2000 S
Greg Janicki, PT 02, works as a physical
therapist in Geneseo, Ill. He invented and is
patenting and manufacturing the TriForce, a
functional fitness and rehabilitation
tool intended to help people achieve
their movement goals.

he Program in Occupational
Therapy is celebrating its 100year anniversary in October 2018.
As part of the Centennial Gala, the
program is recognizing outstanding
alumni for individual achievements
in or contributions to the field of
occupational therapy in research,
education, leadership, professional
development or community
participation. This is the first time
the program has offered the award.
Nominations for the Distinguished
OT Program Alumni Award are being
accepted July 1, 2017-Jan. 31, 2018,
at ot.wustl.edu/otalumniaward.

Jonathan Chung, MD 04, recently started
a new job at The University of Chicago
Medicine as associate section chief of thoracic
imaging and associate professor of radiology.
Valencia Gant, HA 07, SW 07, was
promoted to assistant director of ambulatory surgery services for Texas Children’s
Hospital The Woodlands.
Shandiz Tehrani, MD/PhD 08, is an
assistant professor of ophthalmology at
Oregon Health & Science University, where
he specializes in the clinical and surgical care
of adult glaucoma. His research interests
include the cellular and molecular mechanisms of glaucomatous optic nerve damage,
with the ultimate goal of identifying novel
pathways for therapeutic intervention.
Amit Patel, MD 10, recently moved to
North Carolina to take a position as assistant
professor of medicine in the Division of
Gastroenterology at Duke University School
of Medicine.
Daniel Seitz, MD 13, graduated from
the Indiana University School of Medicine
Emergency Medicine Residency Program and
has started a fellowship in clinical informatics
at the Regenstrief Institute in Indianapolis.

Outlook 31

obituaries
Transplant pioneer dies at 78
Helped establish kidney transplantation program at Barnes-Jewish Hospital

C

harles B. Anderson, MD, a former professor and director of the
Division of General Surgery, died of congestive heart failure
Monday, Nov. 7, 2016, at his home in St. Louis. He was 78.
Anderson’s research and surgical expertise advanced the
understanding of kidney transplantation and helped to establish the
kidney transplantation program at Barnes-Jewish Hospital, where he
served as general surgeon-in-chief.
He is widely respected for his work to combat organ rejection in
Charles B. Anderson, MD kidney transplant patients. He proposed pre-surgical blood
transfusions from organ donors, which provided recipients with protective antibodies and
immunosuppression. The scientific community considered the concept controversial in the
1970s when introduced by Anderson and his associate William T. Newton, MD, a former
professor of surgery. However, it since has been accepted internationally.
He and Newton also established the pediatric kidney transplant program at St. Louis
Children’s Hospital.
With colleague Gregorio A. Sicard, MD, a professor emeritus of surgery, Anderson
developed vascular surgery into a specialty. Anderson was among the first U.S. surgeons to
be certified in vascular surgery by the American Board of Surgery.
Anderson earned a bachelor’s degree from Johns Hopkins University in 1958 and medical
degree from Yale University in 1962. He also completed an internship and residency in surgery
at then-Barnes Hospital. Anderson served as a U.S. Navy medical officer from 1963 to 1965.
He was named full professor in 1979 and became director of the general surgery division in 1984.
Anderson married Marilynn Virginia Wolf in 1967. She preceded him in death. Survivors
include his children, Kristin A. Redington (Jim), Cheryl A. Colonnello (Jamie) and Beth A.
Stiska (Matt); and eight grandchildren.

Matthew R. Barton,
MD, a physician-scientist in his seventh and
final year of residency
in otolaryngology at
Barnes-Jewish Hospital
and Washington
University School of
Medicine, died unexpectedly Monday, Jan.
23, 2017, at his home in Webster Groves,
Mo., of an undiagnosed medical condition.
He was 35.
While in medical school, a research rotation at the National Institutes of Health (NIH)
in Bethesda, Md., introduced him to academic medicine and clinical investigation.
The experience made him want to become a
physician-scientist aimed at developing better treatments for otolaryngology patients.
Barton is survived by his wife, Allison
Barton; their children, Noah and Brooklyn;
his parents, Michael and Deborah Barton;
and his sister, Katie Barton.
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Brian T. Collins, MD,
an associate professor
of pathology and
immunology, died
Friday, Dec. 23, 2016,
in his sleep at his
home in Creve Coeur,
Mo. He was 52.
Chief of the cytopathology section at
the school, his work focused on studying
and diagnosing diseases on the cellular
level, with a particular emphasis on using
fine needles to rapidly obtain samples for
molecular and other diagnostic tests.
Collins is survived by his wife, Virginia
“Gini” Collins; children, Virginia A. “Gini,”
Laura, John, Dianne and Maria Collins;
parents, Steven and Virginia Collins; and
brother, Scott Collins.
.

1940 S
Joseph Hunter Allen Jr., MD 48; Sept. ‘16
Aaron Birenbaum, MD 48; Nov. ‘16
Charles Glendenning Fullenwider, MD
43; Oct. ‘16
Wilbert “Bill” Edgar Hieb, MD 44; March ‘16
Richard A. Preston, MD 42; Sept. ‘16
Clarence G. Schulz, MD 45; Nov. ‘16
Ruth E. Werner, OT 49; Jan. ‘17

1950 S
Melvin H. Becker, LA 44, MD 50; Dec. ‘16
Richard Vernon Bradley, MD 52; Jan. ‘17
John Whitfield Drake II, MD 56; Nov. ‘16
Robert Echols, MD 50; Aug. ‘16
M. Ann Hunt, LA 47, MD 51; Oct. ‘16
Kathryn Mary Defler Lavrich, MD 51;
Nov. ‘16
Ruth Lynch, NU 55; Nov. ’16
Joseph Kent McKinney, MD 58; Nov. ‘16
Robert Calvin Newell, MD 57; Aug. ‘16
Lloyd Hamilton Ramsey, MD 50; Oct. ‘16
Irwin “Izzy” Schultz, HS 56; Nov. ‘16
L.D. (Lari Daniel) Slane, DE 50; Jan. ‘17
Ethelee R. Smith, MD 56; Sept. ‘16
Stanley B. Smith, MD 56; Nov. ‘16
Herbert Sunshine, LA 50, MD 54, HS; Dec. ‘16
Gordon Clay Thompson, DE 52; Oct. ‘16
John C. Whitsell, MD 54; Oct. ‘16
Robert D. Winship, MD 53; Sept. ‘16

1960 S
Sheftel Japhe “Shep” Cohen, MD 63; Oct. ‘16
Joann Miriam Gellman, NU 63; Nov. ‘16
John Hered, MD 67; Oct. ‘16
Michael J. Perley, MD 61; Sept. ‘16
Collyn Franzenburg Schmidt, GN 61; Oct. ‘16

1970 S
Aaron M. Bernstein, LA 48, HS 73; Nov. ‘16
Chauncey C. Maher III, MD 72; Dec. ‘16
Janet Williamson, OT 71; Oct. ‘16

For full obituaries, visit:
wumcnews.org/obits
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S. HULTGREN, V. O’BRIEN, M. JOENS, J. FITZPATRICK

Science
as art
outlook.wustl.edu

I

n this scanning electron microscope image, white blood cells (yellow-green)
fail to control the bacteria (pink) causing a urinary tract infection in a
mouse bladder (blue). The alluring image is a winner in the annual BioArt
competition sponsored by the Federation of American Societies for
Experimental Biology. The image was submitted by Scott Hultgren, PhD,
the Helen L. Stoever Professor of Molecular Microbiology; Valerie O’Brien,
a graduate student in Hultgren’s lab; James Fitzpatrick, PhD, director of
the Center for Cellular Imaging; and Matthew Joens, a staff scientist in the
Department of Neuroscience.
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Linked together

2 Washington University School of Medicine
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As part of an integrated campus plan, a new elevated walkway
connects four employee garages to medical school buildings
and hospitals, eliminating the need to cross busy traffic
intersections. For added safety and comfort, the walkway
requires badge-swipe access and contains emergency phones,
benches, restrooms and a coffee shop. See story on page 7.
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